Newswire
ภาษาไทย
English-
CISION PR Newswire - uCloudlink Introduces New GlocalMe® Life Series at...
PARIS, May 23, 2024 /PRNewswire/ -- GlocalMe®, the digital lifestyle brand under uCloudLink Group Inc. ("uCloudlink") (NASDAQ: UCL), today introduced three new products at VivaTech 2024. The GlocalMe ... -
CISION PR Newswire - Global Innovators Gather at BEYOND Expo 2024 Openi...
MACAO, May 23, 2024 /PRNewswire/ -- The BEYOND Expo 2024 commenced with a spectacular opening ceremony on May 22 at the Venetian Theatre in the Venetian Macao. The ceremony brought together global lea... -
CISION PR Newswire - FPD factory utilization poised for recovery and gr...
LONDON, May 23, 2024 /PRNewswire/ -- Over the course of the flat panel display (FPD) industry's history, factory utilization has typically averaged approximately 84%. However, from 3Q22 to 4Q23, as th... -
CISION PR Newswire - Computex 2024: DeCloak Intelligences Showcases DeC...
LAS VEGAS and TAIPEI, May 23, 2024 /PRNewswire/ -- DeCloak Intelligences, a subsidiary of Etron Technology (TPEx: 5351), has won the CES Innovation Award for two consecutive years and its privacy syst... -
CISION PR Newswire - Unlock the Future of Innovation: Taiwan's Premier ...
A Crucial Exchange Hub for Global Net-Zero Initiatives and AI-Driven Manufacturing Solutions TAIPEI, May 24, 2024 /PRNewswire/ -- As industries worldwide grapple with the transition to net-zero operat... -
CISION PR Newswire - Jia Xudong, partner of Fintopia, emphasized the im...
BEIJING, May 24, 2024 /PRNewswire/ -- A news report from ifeng.com: Recently, the Alibaba Cloud International Summit, with the core theme of "Orange Cloud Going Global, New Journey of Financial Techno... -
CISION PR Newswire - ASCO 2024 | Ascentage Pharma Releases Latest Resul...
SUZHOU, China and ROCKVILLE, Md., May 24, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB... -
CISION PR Newswire - Busting fear barrier about hormone replacement the...
MANILA, Philippines, May 24, 2024 /PRNewswire/ -- Millions of women around the world continue to suffer unnecessarily from the physical and psychological effects of the menopause because of "mistaken ... -
CISION PR Newswire - Antengene To Present One Oral and Four Abstracts a...
Oral Presentation：a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in patients with cervical cancer Three Poster presentations: Phase I/II studi... -
CISION PR Newswire - CNOOC Limited Subsidiaries Signed EPCCs with MIREM...
HONG KONG, May 24, 2024 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces its wholly owned subsidiaries have entered into petroleu...
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ELITE Beauty.